BioSpace News Archive

Bio NC

Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress.

October 26, 2023
·
7 min read
Business

Lisata Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 2nd at 4:30 p.m. Eastern Time

Lisata Therapeutics, Inc. announced that the Company will report its financial results for third quarter ended September 30, 2023, on Thursday, November 2, 2023, after the close of trading and will host a conference call at 4:30 p.m. Eastern time.

October 26, 2023
·
1 min read
Business

Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2

Vaxart, Inc. announced it will provide a business update and report financial results for the third quarter ended September 30, 2023 after the market close on Thursday, November 2, 2023.

October 26, 2023
·
1 min read
BioMidwest

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.

October 26, 2023
·
8 min read
Drug Development

NKGen Biotech Presented Phase I Clinical Trial Data at the 16th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

NKGen Biotech Inc. today presented a poster with Phase I trial data on the use of its investigational NK cell therapy, SNK01, to treat patients with Alzheimer’s disease (AD) at the Clinical Trials on Alzheimer’s Disease (CTAD) Annual Meeting in Boston, MA.

October 26, 2023
·
7 min read
Biotech Beach

Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting

Bionano Genomics, Inc. today announced its participation in the American Society of Human Genetics (ASHG) Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping (OGM) for cell bioprocessing quality control and constitutional genetic disorder research.

October 26, 2023
·
10 min read
Drug Development

Triumvira Immunologics Announces First Patient Dosed in Phase II of TACTIC-2 Cell Therapy Trial for the Treatment of HER2+ Gastric and GEJ Cancers

Triumvira Immunologics announced that the first patient has been dosed in Phase II of its Phase I/II study TACTIC-2 investigating the safety and efficacy of autologous TAC-T cell lead asset, TAC01-HER2, in targeting HER2 in relapsed or refractory gastric and gastroesophageal junction tumors.

October 26, 2023
·
2 min read
Drug Development

Tonix Pharmaceuticals Completes Clinical Stage of Phase 2 PREVENTION Study of TNX-1900 for the Prevention of Migraine Headaches in Chronic Migraineurs

Tonix Pharmaceuticals Holding Corp. announced the completion of the clinical phase of the Phase 2 proof-of-concept, double-blind, randomized, placebo-controlled PREVENTION1 study of TNX-19002 as a potential treatment for the prevention of migraine headaches in chronic migraineurs.

October 26, 2023
·
12 min read
Business

Karyopharm to Report Third Quarter 2023 Financial Results on November 2, 2023

Karyopharm Therapeutics Inc. today announced it will report third quarter 2023 financial results on Thursday, November 2, 2023.

October 26, 2023
·
2 min read
Business

Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023

Agile Therapeutics, Inc., a women’s healthcare company, announced it will report third quarter 2023 financial results before the market open on Thursday, November 9, 2023.

October 26, 2023
·
1 min read